The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/19595
StudyName: Eligibility Breast Cancer NCT00379015
Date of export from the portal: 02.07.2020
Date of Upload / last change: 13.01.2017
License: Creative Commons BY 4.0

----

Description: 
Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00379015
